As of 2026-09-27, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (3.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.29 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -1163.9%.
The range of the Relative Valuation is (2.76) - (3.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 23.0x | 19.1x |
| Forward P/E multiples | 14.0x - 21.7x | 15.7x |
| Fair Price | (2.76) - (3.90) | (3.13) |
| Upside | -1036.7% - -1426.8% | -1163.9% |
| Date | P/E |
| 2026-09-25 | -1.64 |
| 2026-09-24 | -1.61 |
| 2026-09-23 | -1.62 |
| 2026-09-22 | -1.66 |
| 2026-09-21 | -1.50 |
| 2026-09-18 | -1.72 |
| 2026-09-17 | -1.75 |
| 2026-09-16 | -1.77 |
| 2026-09-15 | -1.75 |
| 2026-09-14 | -1.75 |
| 2026-09-11 | -1.75 |
| 2026-09-10 | -1.79 |
| 2026-09-09 | -1.85 |
| 2026-09-08 | -1.95 |
| 2026-09-04 | -1.91 |
| 2026-09-03 | -1.83 |
| 2026-09-02 | -1.74 |
| 2026-09-01 | -1.75 |
| 2026-08-31 | -1.77 |
| 2026-08-28 | -1.82 |
| 2026-08-27 | -1.85 |
| 2026-08-26 | -1.74 |
| 2026-08-25 | -1.80 |
| 2026-08-24 | -1.79 |
| 2026-08-21 | -1.77 |
| 2026-08-20 | -1.72 |
| 2026-08-19 | -1.75 |
| 2026-08-18 | -1.67 |
| 2026-08-17 | -1.78 |
| 2026-08-14 | -1.87 |
| 2026-08-13 | -1.86 |
| 2026-08-12 | -1.90 |
| 2026-08-11 | -1.80 |
| 2026-08-10 | -1.86 |
| 2026-08-07 | -2.73 |
| 2026-08-06 | -2.77 |
| 2026-08-05 | -2.81 |
| 2026-08-04 | -2.84 |
| 2026-08-03 | -2.84 |
| 2026-07-31 | -2.76 |
| 2026-07-30 | -2.77 |
| 2026-07-29 | -2.74 |
| 2026-07-28 | -2.70 |
| 2026-07-27 | -2.55 |
| 2026-07-24 | -2.53 |
| 2026-07-23 | -2.55 |
| 2026-07-22 | -2.60 |
| 2026-07-21 | -2.65 |
| 2026-07-20 | -2.67 |
| 2026-07-17 | -2.62 |